case_images: PMC7731902_01
case_images: Timeline of systematic treatment.
case_images: fendo-11-594264-g001.jpg
case_images: PMC7731902_01_fendo-11-594264-g001.jpg
case_images: f1
case_images: A timeline of his systemic treatment is provided in  Figure 1 .
case_images: Imaging at baseline and after 18 months of nivolumab plus cabozantinib.
case_images: fendo-11-594264-g002.jpg
case_images: PMC7731902_01_fendo-11-594264-g002.jpg
case_images: f2
case_images: Cabozantinib was dosed at 40 mg by mouth daily and nivolumab was provided at 240 mg IV every 2 weeks as per the phase I study by Apolo et al.  Figure 2  contrasts his baseline imaging studies with the ones obtained 18 months after treatment initiation.
case_images: Right lower extremity shin ulcerations.
case_images: fendo-11-594264-g003.jpg
case_images: PMC7731902_01_fendo-11-594264-g003.jpg
case_images: f3
case_images: The patient's course was complicated by several events including ulcerations on his lower extremities shown in  Figure 3 .